The European Commission's Joint Research Centre (JCR) has released 10 new evidence-based recommendations on how mammogram results and follow-up appointments should be communicated to women within breast cancer screening programmes.
The recommendations have been developed as part of the European Commission Initiative on Breast Cancer (ECIBC).
The ECIBC's Guidelines Development Group recommends using letters to inform women who have a negative screening result (conditional recommendation, very low certainty in the evidence) and advises against relaying the information in a phone call or face-to-face meeting.
The ECIBC suggests using either a letter including a GP’s signature, a letter including a fixed appointment, a letter followed by a phone reminder or a letter followed by a written reminder, over letters alone, for inviting women to subsequent breast cancer screening rounds (conditional recommendation, moderate to high certainty in the evidence).
There are now 50 publicly accessible ECIBC recommendations on breast cancer screening and diagnosis, and a further 30 will be published later this year. It is expected that the final 80 ECIBC recommendations will cover strategies for the organisation of screening programmes, types of screening tests, diagnostic methods, communication approaches and the training of professionals involved in breast cancer screening and diagnosis.